China's National Health Commission confirmed today that the death toll from the coronavirus outbreak has risen to 170 as confirmed cases have surged past 8,200. Russia has said it plans to close its 2,600-mile border with China to prevent the spread of the virus, while a cruise ship in Italy with 7,000 on board ...
Macom Technology Solutions (NASDAQ: MTSI): Macom Technology shares jumped as much as 19% yesterday after the networking semiconductor company reported fiscal Q1 results. Macom reported adjusted earnings per share of $0.07 on revenue of $119 million, compared to analysts' estimates for earnings per share of $0.03 on revenue of $115 million. "We view 5G as a key driver for Macom revenue in the years ahead ...
|
100% profit targets weekly - Options Genius shares his simple system to profit on options trades every single week with just 1 trade. If you are looking for 1 perfect trading idea to generate consistent profits you have to watch his short video. (ad)
|
Income expert Neil George has just released a new book called Income for Life. Inside, it details more than 65 little-known income streams that ANYONE can collect. However, this book is not available for sale. Instead, we're on a nationwide campaign to spread the book far and wide for FREE. (ad)
| | |
The market started the year off strong, pushing to a new all-time high before dropping sharply back in the last week. The enthusiasm associated with the completion of Phase One of the U.S.-China trade deal seems to have been offset by concerns about the ramifications of the coronavirus in China.
|
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. |
Many traders become obsessed with the big win. But successful trading isn't about hitting home runs, it's about raising your batting average.
Rob Booker has the blueprint for steady, reliable account growth, like $100 a day, every day, even with tiny accounts. Do you want to leverage incredible risk/reward ratios in your favor?
| Trend Following Picks
Reversal Picks
| | | Already subscribed to our premium service?
Not a TradersPro subscriber yet?
| | | | |
This email was sent to its028@gmail.com by Investiv, LLC
Disclaimers
Investing is Inherently Risky
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Hypothetical Results Are Reported
Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage.
The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading.
Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Offers Disinterested Commentary and Analysis
The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations.
The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase.
Disclaimers, Terms & Conditions | Privacy Policy
Copyright © 2019 | |
|
|
|
|
没有评论:
发表评论